316 related articles for article (PubMed ID: 17491587)
1. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
2. Bevacizumab in the treatment of colorectal cancer.
Marshall JL
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
[No Abstract] [Full Text] [Related]
3. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
4. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX.
Leite D; Kater FR
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S1-7. PubMed ID: 21768791
[TBL] [Abstract][Full Text] [Related]
5. Perforating dermatosis in a patient receiving bevacizumab.
Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
[No Abstract] [Full Text] [Related]
6. Accrual delayed in adjuvant bevacizumab trial.
Tuma RS
J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
[No Abstract] [Full Text] [Related]
7. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
8. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience.
Siperstein AE; Berber E; Ballem N; Parikh RT
Ann Surg; 2007 Oct; 246(4):559-65; discussion 565-7. PubMed ID: 17893492
[TBL] [Abstract][Full Text] [Related]
9. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
10. Panitumumab in metastatic colorectal cancer.
Wisinski KB; Mulcahy MF; Benson AB
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):10-1. PubMed ID: 17491586
[No Abstract] [Full Text] [Related]
11. [Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008].
Mansueto G; Longo F
Tumori; 2008; 94(4):suppl 1-14. PubMed ID: 18822711
[No Abstract] [Full Text] [Related]
12. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
Klinger M; Tamandl D; Eipeldauer S; Hacker S; Herberger B; Kaczirek K; Dorfmeister M; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2010 Aug; 17(8):2059-65. PubMed ID: 20177795
[TBL] [Abstract][Full Text] [Related]
13. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
[TBL] [Abstract][Full Text] [Related]
14. [A case with liver resection of metastasis from rectal cancer after bevacizumab treatment].
Nishida K; Matsuyama T; Masuda D; Hosokawa T; Tokita H; Kakimoto M; Goto H; Yoshimura T; Koshiishi H; Okamura T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2517-9. PubMed ID: 21224625
[TBL] [Abstract][Full Text] [Related]
15. Onset of segmental colitis associated with diverticulosis after treatment with bevacizumab for metastatic colorectal carcinoma.
Tursi A
J Crohns Colitis; 2012 Aug; 6(7):809-10. PubMed ID: 22658805
[No Abstract] [Full Text] [Related]
16. Sequential or combination chemotherapy for a patient with mCRC?
Arnold D
Cancer Treat Rev; 2008; 34 Suppl 2():S12-6. PubMed ID: 19101403
[TBL] [Abstract][Full Text] [Related]
17. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
Rodriguez NA; Ascaso FJ
J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
[No Abstract] [Full Text] [Related]
18. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
[No Abstract] [Full Text] [Related]
19. Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer.
Vaidyanathan G; Groman A; Wilding G; Fakih MG
Oncology; 2010; 79(1-2):67-71. PubMed ID: 21071992
[TBL] [Abstract][Full Text] [Related]
20. [An elderly colon cancer patient with hepatic, lunge and peritoneal metastases was treated by hepatic arterial infusion and systemic chemotherapy-a case report].
Ando M; Nagahama T; Fukuda A; Ami K; Kurokawa T; Hataji K; Ganno H; Kawasaki N; Arai K; Okada Y; Tei S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2288-90. PubMed ID: 21224550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
